PL3670522T3 - Krystaliczna postać chlorku rybozydu nikotynamidu - Google Patents
Krystaliczna postać chlorku rybozydu nikotynamiduInfo
- Publication number
- PL3670522T3 PL3670522T3 PL20153772T PL20153772T PL3670522T3 PL 3670522 T3 PL3670522 T3 PL 3670522T3 PL 20153772 T PL20153772 T PL 20153772T PL 20153772 T PL20153772 T PL 20153772T PL 3670522 T3 PL3670522 T3 PL 3670522T3
- Authority
- PL
- Poland
- Prior art keywords
- crystalline form
- nicotinamide riboside
- riboside chloride
- chloride
- nicotinamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/048—Pyridine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462028702P | 2014-07-24 | 2014-07-24 | |
EP20153772.7A EP3670522B1 (en) | 2014-07-24 | 2015-07-24 | Crystalline form of nicotinamide riboside chloride |
EP15825253.6A EP3174891B1 (en) | 2014-07-24 | 2015-07-24 | Crystalline form of nicotinamide riboside |
PCT/US2015/041956 WO2016014927A2 (en) | 2014-07-24 | 2015-07-24 | Crystalline form of nicotinamide riboside |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3670522T3 true PL3670522T3 (pl) | 2022-02-21 |
Family
ID=55163976
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL20153772T PL3670522T3 (pl) | 2014-07-24 | 2015-07-24 | Krystaliczna postać chlorku rybozydu nikotynamidu |
PL15825253T PL3174891T3 (pl) | 2014-07-24 | 2015-07-24 | Krystaliczna postać rybozydu nikotynamidu |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL15825253T PL3174891T3 (pl) | 2014-07-24 | 2015-07-24 | Krystaliczna postać rybozydu nikotynamidu |
Country Status (7)
Country | Link |
---|---|
US (2) | US10323058B2 (pl) |
EP (2) | EP3670522B1 (pl) |
CN (1) | CN106715454B (pl) |
CA (1) | CA2956163C (pl) |
ES (2) | ES2776395T3 (pl) |
PL (2) | PL3670522T3 (pl) |
WO (1) | WO2016014927A2 (pl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3268379B1 (en) * | 2015-03-09 | 2023-11-01 | W.R. Grace & CO. - CONN. | Crystalline form of nicotinamide riboside |
EA035664B1 (ru) | 2015-08-05 | 2020-07-23 | МЕТРО ИНТЕРНЭШНЛ БАЙОТЕК, ЭлЭлСи | Производные никотинамидмононуклеотида и их применение для лечения заболевания или расстройства, связанного с биосинтезом над+ |
GB2542881B (en) | 2015-10-02 | 2020-01-01 | Carr Andrew | Crystal forms of ß-nicotinamide mononucleotide |
CA3017254C (en) | 2016-03-16 | 2023-08-22 | ChromaDex Inc. | B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof |
WO2017218580A1 (en) | 2016-06-14 | 2017-12-21 | Rejuvenation Therapeutics Corporation | Synthetic methods for the preparation of nicotinamide riboside and related compounds |
CA3045876A1 (en) | 2016-11-11 | 2018-05-17 | The Queen's University Of Belfast | Scalable syntheses of nicotinoyl ribosides and reduced nic otinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof |
AU2017367092B2 (en) | 2016-11-29 | 2022-11-03 | University Of Iowa Research Foundation | Use of NAD precursors for improving maternal health and/or offspring health |
US11071747B2 (en) | 2016-11-29 | 2021-07-27 | University Of Iowa Research Foundation | Use of NAD precursors for breast enhancement |
SG11201912267SA (en) | 2017-06-19 | 2020-01-30 | Gangadhara Ganapati | Nicotinamide riboside derivatives and their uses |
CN112020363A (zh) * | 2017-12-22 | 2020-12-01 | 益力舒健康公司 | 烟酰胺核苷氯化物的结晶形式 |
AU2019214858B2 (en) | 2018-01-30 | 2023-02-02 | Metro International Biotech, Llc | Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof |
EP3794007A1 (en) * | 2018-05-18 | 2021-03-24 | Roche Diagnostics GmbH | (thio)nicotinamide ribofuranoside salts and compositions, methods of making, and uses thereof |
CN108774278A (zh) * | 2018-09-10 | 2018-11-09 | 张洪喜 | 一种制备尼克酰胺核苷盐的方法 |
CA3122527A1 (en) | 2018-12-10 | 2020-06-18 | ChromaDex Inc. | Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof |
WO2020131578A2 (en) | 2018-12-17 | 2020-06-25 | Mitopower Llc | Nicotinyl riboside compounds and their uses |
MX2021010043A (es) * | 2019-02-21 | 2022-07-19 | Chromadex Inc | Uso de nicotinamida ribósido, ácido nicotinico ribósido, compuestos de nicotinil ribósido reducido y derivados de compuestos de nicotinil ribósido en formulaciones. |
US10618927B1 (en) | 2019-03-22 | 2020-04-14 | Metro International Biotech, Llc | Compositions and methods for modulation of nicotinamide adenine dinucleotide |
US11939348B2 (en) | 2019-03-22 | 2024-03-26 | Metro International Biotech, Llc | Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide |
KR20220039747A (ko) | 2019-07-19 | 2022-03-29 | 바이오신스 아게 | 니코틴아미드 리보푸라노사이드 염의 제조 방법, 니코틴아미드 리보푸라노사이드 염, 및 이의 용도 |
CN111808156A (zh) * | 2020-07-15 | 2020-10-23 | 许昌远志生物科技有限公司 | 一种β-烟酰胺核糖氯化物的晶型1A、晶型1B及其制备方法 |
CN117545488A (zh) | 2021-05-27 | 2024-02-09 | 麦德龙国际生物科技有限责任公司 | 烟酸单核苷酸及其酯的结晶固体以及其制作和使用方法 |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1190080A (en) | 1966-08-08 | 1970-04-29 | Kyowa Hakko Kogyo Company Ltd | Process for producing Nicotinamide Adenine Dinucleotide |
US3728111A (en) | 1971-09-21 | 1973-04-17 | Asea Ab | Method of manufacturing billets from powder |
US6348589B1 (en) | 1997-02-06 | 2002-02-19 | Inspire Pharmaceuticals, Inc. | Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
GB9712370D0 (en) | 1997-06-14 | 1997-08-13 | Aepact Ltd | Therapeutic systems |
AU2002232660A1 (en) | 2000-12-15 | 2002-06-24 | Pharmasset Ltd. | Antiviral agents for treatment of flaviviridae infections |
US7179791B2 (en) | 2001-01-11 | 2007-02-20 | Duke University | Inhibiting GS-FDH to modulate NO bioactivity |
US7977049B2 (en) * | 2002-08-09 | 2011-07-12 | President And Fellows Of Harvard College | Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
US20050020587A1 (en) * | 2003-07-25 | 2005-01-27 | Pfizer Inc | Nicotinamide derivatives useful as PDE4 inhibitors |
US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
US8114626B2 (en) | 2004-02-10 | 2012-02-14 | Trustees Of Dartmouth College | Yeast strain and method for using the same to produce nicotinamide riboside |
CA2555675A1 (en) | 2004-02-10 | 2005-08-25 | Trustees Of Dartmouth College | Nicotinamide riboside kinase compositions and methods for using the same |
WO2006001982A2 (en) | 2004-06-04 | 2006-01-05 | Washington University | Methods and compositions for treating neuropathies |
NZ561613A (en) | 2005-02-18 | 2010-12-24 | Astrazeneca Ab | Antibacterial piperidine derivatives |
WO2006105440A2 (en) | 2005-03-30 | 2006-10-05 | Sirtris Pharmaceuticals, Inc. | Nicotinamide riboside and analogues thereof |
US20070149466A1 (en) | 2005-07-07 | 2007-06-28 | Michael Milburn | Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
WO2007061798A2 (en) | 2005-11-18 | 2007-05-31 | Cornell Research Foundation, Inc. | Nicotinoyl riboside compositions and methods of use |
AU2006339607A1 (en) | 2005-12-02 | 2007-09-13 | Sirtris Pharmaceuticals, Inc. | Modulators of Cdc2-like kinases (Clks) and methods of use thereof |
WO2007136744A1 (en) | 2006-05-19 | 2007-11-29 | The Johns Hopkins University | Crystal structure of a substrate complex of nampt/pbef/visfatin |
EP2129660A2 (en) * | 2006-12-19 | 2009-12-09 | Pfizer Products Inc. | Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
CA2676609A1 (en) | 2007-01-26 | 2008-07-31 | Washington University | Methods and compositions for treating neuropathies |
US20110306597A1 (en) * | 2008-06-18 | 2011-12-15 | James Michael Crawforth | Nicotinamide Derivatives |
WO2010002586A2 (en) | 2008-06-30 | 2010-01-07 | Elc Management Llc | Topical compositions comprising isonicotinamide |
WO2010017374A1 (en) | 2008-08-06 | 2010-02-11 | Sicor Inc. | Process for preparing azacytidine intermediate |
WO2011005289A2 (en) | 2009-06-23 | 2011-01-13 | President And Fellows Of Harvard College | Methods and kits for measuring enzyme activity |
UA108856C2 (uk) | 2009-07-24 | 2015-06-25 | Пунікалін (punicalin) та пунікалагін (punicalagin) для захисту здоров'я головного мозку при нейродегенеративних розладах | |
US8507251B2 (en) | 2009-09-28 | 2013-08-13 | Robert J. Greenstein | Medium and method for culturing Mycobacterium avium subspecies paratuberculosis |
WO2011081942A1 (en) * | 2009-12-14 | 2011-07-07 | Cornell University | Activation and activators of sirt5 |
EP2464249B1 (de) | 2010-03-29 | 2013-03-13 | Johannes Huber | Konzentrationssteigerndes getränk |
US8481711B2 (en) | 2010-07-06 | 2013-07-09 | Hidenori Kamanishi | Neurite outgrowth agent |
US20140065099A1 (en) | 2011-02-15 | 2014-03-06 | Ecole Polytechnique Federale De Lausanne (Epfl) | Methods of Treating Mitochondrial Dysfunction |
US20120107888A1 (en) | 2011-02-17 | 2012-05-03 | Qteros, Inc. | Modulation of fermentation products through vitamin supplementation |
US20120328526A1 (en) | 2011-06-27 | 2012-12-27 | University Of Maryland, Baltimore | Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof |
EP3345901A3 (en) | 2011-06-29 | 2018-09-12 | President and Fellows of Harvard College | Small molecules as antiaging agents |
WO2013002880A1 (en) | 2011-06-29 | 2013-01-03 | The General Hospital Corporation | Compositions and methods for enhancing bioenergetic status in female germ cells |
EP2869717B8 (en) | 2012-07-09 | 2018-07-25 | NoGlo, Inc. | Prevention of alcohol reaction with dietary supplements |
US20140256760A1 (en) | 2012-07-09 | 2014-09-11 | Noglo Llc | Reduction or prevention of alcohol reaction with dietary supplements |
US9861651B2 (en) | 2012-07-16 | 2018-01-09 | Cornell University | Use of nicotinamide riboside to treat hearing loss |
WO2014059029A1 (en) | 2012-10-09 | 2014-04-17 | President And Fellows Of Harvard College | Treatment of age-related and mitochondrial diseases by inhibition of hif-1 alpha function |
WO2014111906A1 (en) | 2013-01-21 | 2014-07-24 | Ecole Polytechnique Federale De Lausanne (Epfl) | Bioluminescence imaging of small biomolecules |
CN105228627B (zh) | 2013-03-15 | 2018-07-13 | 纽斯尔特科学公司 | 亮氨酸和烟酸降低脂质水平 |
GB201313465D0 (en) * | 2013-07-29 | 2013-09-11 | Queens University Of The Belfast | Methods of preparing nicotinamide riboside and derivatives thereof |
CN105682748B (zh) | 2013-10-24 | 2021-03-12 | 宝洁公司 | 亮肤化妆品组合物及方法 |
WO2015064988A1 (ko) | 2013-10-29 | 2015-05-07 | 한림대학교 산학협력단 | 니코틴아마이드 라이보사이드를 유효성분으로 포함하는 패혈증 치료 또는 예방용 약제학적 조성물 |
KR20220098049A (ko) | 2013-10-30 | 2022-07-08 | 크로마덱스 아이엔씨. | 피부 질환 치료에서의 국소적 사용을 위한 니코틴아미드 리보사이드 조성물 |
CA2929666C (en) | 2013-11-12 | 2023-08-01 | Ortho-Nutra, Llc | Theacrine-based supplement and method of use thereof |
WO2015099842A1 (en) | 2013-12-23 | 2015-07-02 | Abbott Laboratories | Hot beverage fortifier |
AU2015229055B2 (en) | 2014-03-13 | 2019-09-12 | Salk Institute For Biological Studies | Analogs of fexaramine and methods of making and using |
CA2942403A1 (en) | 2014-03-13 | 2015-09-17 | Salk Institute For Biological Studies | Fxr agonists and methods for making and using |
US20150297508A1 (en) | 2014-04-21 | 2015-10-22 | William Andriette | Topical Formulation to Enhance Genital Sensation and Function |
US10316054B2 (en) * | 2014-06-02 | 2019-06-11 | Glaxosmithkline Intellectual Property (No. 2) Limited | Preparation and use of crystalline beta-D-nicotinamide riboside |
RU2016149767A (ru) | 2014-06-06 | 2018-07-16 | Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед | Аналоги никотинамидрибозида и фармацевтические композиции и их применение |
EP3169333A4 (en) | 2014-07-17 | 2018-03-07 | The Scripps Research Institute | Methods and compositions for enhancing cancer therapy |
EP3268379B1 (en) * | 2015-03-09 | 2023-11-01 | W.R. Grace & CO. - CONN. | Crystalline form of nicotinamide riboside |
-
2015
- 2015-07-24 US US15/328,664 patent/US10323058B2/en active Active
- 2015-07-24 CA CA2956163A patent/CA2956163C/en active Active
- 2015-07-24 EP EP20153772.7A patent/EP3670522B1/en active Active
- 2015-07-24 ES ES15825253T patent/ES2776395T3/es active Active
- 2015-07-24 WO PCT/US2015/041956 patent/WO2016014927A2/en active Application Filing
- 2015-07-24 CN CN201580051724.1A patent/CN106715454B/zh active Active
- 2015-07-24 EP EP15825253.6A patent/EP3174891B1/en active Active
- 2015-07-24 PL PL20153772T patent/PL3670522T3/pl unknown
- 2015-07-24 ES ES20153772T patent/ES2908332T3/es active Active
- 2015-07-24 PL PL15825253T patent/PL3174891T3/pl unknown
-
2017
- 2017-10-23 US US15/791,097 patent/US10233207B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20180086783A1 (en) | 2018-03-29 |
US10233207B2 (en) | 2019-03-19 |
WO2016014927A2 (en) | 2016-01-28 |
EP3174891A2 (en) | 2017-06-07 |
PL3174891T3 (pl) | 2020-08-10 |
ES2908332T3 (es) | 2022-04-28 |
ES2776395T3 (es) | 2020-07-30 |
US10323058B2 (en) | 2019-06-18 |
CN106715454B (zh) | 2020-06-16 |
CN106715454A (zh) | 2017-05-24 |
EP3670522B1 (en) | 2022-01-19 |
WO2016014927A3 (en) | 2016-09-15 |
US20170210774A1 (en) | 2017-07-27 |
EP3174891A4 (en) | 2018-05-30 |
CA2956163A1 (en) | 2016-01-28 |
EP3174891B1 (en) | 2020-01-29 |
EP3670522A1 (en) | 2020-06-24 |
CA2956163C (en) | 2023-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1247726A1 (zh) | 烟酰胺核苷的結晶形式 | |
PL3670522T3 (pl) | Krystaliczna postać chlorku rybozydu nikotynamidu | |
GB2542881B (en) | Crystal forms of ß-nicotinamide mononucleotide | |
HK1243714A1 (zh) | 製備取代的核苷類似物的方法 | |
HRP20190432T1 (hr) | Spojevi pladienolid piridina i postupci uporabe | |
ZA201608843B (en) | Chloride salt of tat-nr2b9c | |
HK1255112A1 (zh) | 吉西他濱的晶型 | |
SI3380554T2 (sl) | Kristalne oblike per-kloro-gama-ciklodekstrinov | |
HK1244274A1 (zh) | C21h22ci2n4o2的晶型 | |
IL253479A0 (en) | Crystalline forms of efinconazole | |
PL3113773T3 (pl) | Krystaliczne postaci grapiprantu | |
IL251863A0 (en) | Crystalline forms of ferric-maltol | |
EP3207034A4 (en) | Anhydrous crystalline form of s-equol | |
HUP1500506A2 (en) | Salts of palbociclib |